News in English
Октябрь
2024
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31

Новости за 03.10.2024

PYMNTS.com 

B2B Card Payments Usher in New Era of Supplier Enablement

For years, the use of cards within B2B payments has been relatively nascent. However, with news Tuesday (Oct. 1) that American Express teamed with Boost Payment Solutions to provide commercial virtual card processing services, buyers and suppliers in the B2B space are increasingly waking up to a new reality. Virtual cards are no longer just […]

Читать дальше...

Telecompaper.com 

FCC creates position of CTO for Enforcement Bureau

(Telecompaper) The FCC's Enforcement Bureau has named Andy Hendrickson to the newly created position of chief technology officer, to provide strategic and technical advice on technological developments...

Business Standard 

'Biased organisation with political agenda': India rejects USCIRF report

India on Thursday trashed a report by the US Commission on International Religious Freedom (USCIRF) and described it as a "biased" organisation with a "political agenda". In its report, the USCIRF that monitors universal right to freedom of religion criticised India for alleged violations of religious freedom. It also recommended to the US state department to declare India a "Country of Particular Concern" (CPC) in the context of religious freedom. In a strong reaction, the Ministry of External Affairs... Читать дальше...

Top Stories (uk) - Google News (com) 

'King Kong' of weight loss jabs Mounjaro to be rolled out on the NHS to tackle obesity - The Mirror

  1. 'King Kong' of weight loss jabs Mounjaro to be rolled out on the NHS to tackle obesity  The Mirror
  2. NHS to roll out Mounjaro weight loss jab to 1.6 million patients  inews
  3. Quarter of a million more Brits to be prescribed weight loss jabs free on the NHS in new drive to crush...  The Sun
  4. NHS to give overweight Brits '£122' jab where average patient loses 20% of body weight  Express
  5. England's NHS to offer Lilly's weight-loss drug to some patients  Reuters